Alkem Laboratories Limited
Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.(Source : 202003-01 Annual Report Page No:107)
What Alkem files
- Others96
- Investor Meet62
- Updates42
- Important22
- Board Meeting11
- PPTs11
Alkem Labs' Board has proposed a final dividend of ₹10 per equity share for FY26. Mark your calendars: August 7, 2026, is the record date to be eligible for this payout. Once shareholders approve at the August 27 AGM, the dividend will be disbursed starting September 1, 2026. Dividend alert...
Alkem Laboratories' Board has proposed a final dividend of Rs. 10 per equity share for the financial year ended March 31, 2026. This dividend awaits shareholder approval at the Annual General Meeting on August 27. The record date for eligibility is August 7. Payments to eligible shareholders will commence from...
Alkem Laboratories' board has declared an interim dividend of ₹43 per equity share for FY2025-26, representing a 2150% payout on the ₹2 face value. To be eligible, investors must hold shares by the record date of February 20, 2026. The dividend payment is scheduled to commence on March 6, 2026....
Alkem Laboratories has declared an interim dividend of Rs. 43 per equity share for FY2025-2026. The record date for determining eligibility for this dividend is Friday, February 20, 2026. Eligible shareholders who hold shares by this date will receive the dividend payment on or from March 6, 2026.
Alkem has declared an Interim Dividend of ₹43 per equity share (2150% on face value) for the financial year 2025-2026. This payout offers direct value to shareholders. The record date for this dividend is February 20, 2026, with payment to eligible shareholders commencing from March 6, 2026. This move reflects...